Novartis maps genome of type-2 diabetes patients
Mon, 12 Feb 2007 08:16 PM EST
... ZURICH (Reuters) - Swiss pharmaceutical company Novartis AG said it has mapped the genome of a large group of type-2 diabetes patients, enabling scientists to better search for the genes causing the disease. ...
Related Topics
- Diabetes - Type 1
- Diabetes - Type 2
- Genes and Gene Therapy
- Juvenile Diabetes
- Diabetes and Pregnancy
- Diabetes Insipidus
- Gestational Diabetes
- Injury Maps
- Diabetes
- Type 2 diabetes
- Type 1 diabetes
- Diabetes Type 1
- Mucopolysaccharidosis
- Human Genome Epidemiology Network
- Seizures (in about half of patients)
- Clinical Trials
- What Your Female Patients Want to Know About Bladder Control
- Vaccinations For HIV/AIDs Patients
- Smoking Cessation and Continued Risk in Cancer Patients
- Periodontal Disease

Not Signed In -

